Abstract

BackgroundHericium erinaceus, also known as lion’s mane mushroom, is a widely distributed edible and medicinal fungus in Asian countries. H. erinaceus harbors diverse bioactive metabolites with anticancer, immunomodulating, anti-inflammatory, antimicrobial, antihypertensive, antidiabetic and neuroprotective properties. Although the chemical synthesis processes of these bioactive metabolites are known, the biosynthetic processes remain unknown.ResultsIn this study, we obtained the transcriptomes of six H. erinaceus strains using next-generation RNA sequencing and investigated the characteristics of the transcriptomes and biosynthesis of bioactive compounds, especially polysaccharides. The transcriptomes ranged in size from 46.58 to 58.14 Mb, with the number of unigenes ranging from 20,902 to 37,259 across the six H. erinaceus strains. Approximately 60% of the unigenes were successfully annotated by comparing sequences against different databases, including the nonredundant (NR), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), clusters of orthologous groups for eukaryotic complete genomes (KOG) and Swiss-Prot databases. Most of the transcripts were putatively involved in signal transduction, carbohydrate metabolism, translation, transport and catabolism, and amino acid metabolism. Genes involved in polysaccharide biosynthesis were identified, and these genes encoded phosphoglucomutase (PGM), glucose phosphate isomerase (PGI), UDP-glucose pyrophosphorylase (UGP), glycoside hydrolase family proteins, glycosyltransferase family proteins and other proteins. Moreover, the putative pathway for the intracellular polysaccharide biosynthesis of H. erinaceus was analyzed. Additionally, the open reading frames (ORFs) and simple sequence repeats (SSRs) were predicted from the transcriptome data of the six strains.ConclusionsOverall, the present study may facilitate the discovery of polysaccharide biosynthesis processes in H. erinaceus and provide useful information for exploring the secondary metabolites in other members of the Basidiomycetes genus.

Highlights

  • Hericium erinaceus, known as lion’s mane mushroom, is a widely distributed edible and medicinal fungus in Asian countries

  • Illumina sequencing and de novo assembly Raw data were generated by sequencing each H. erinaceus strain

  • After the reads were filtered and subjected to quality control, a total of 21 to 46 million clean reads were obtained for H. erinaceus HT-4903, GT-06, CC-02, PZH-05, TJH-03 and TD-04 (Table 1)

Read more

Summary

Introduction

Known as lion’s mane mushroom, is a widely distributed edible and medicinal fungus in Asian countries. H. erinaceus harbors diverse bioactive metabolites with anticancer, immunomodulating, anti-inflammatory, antimicrobial, antihypertensive, antidiabetic and neuroprotective properties. Due to its anticancer, immunomodulating, hypolipidemic, antioxidant, anti-inflammatory, antimicrobial, antihypertensive, antidiabetic and neuroprotective properties (Kim et al 2011a, b, 2013; Khan et al 2013), many studies on the chemical isolation and physiological functions of bioactive metabolites in H. erinaceus have been performed in recent years. The study demonstrated that polysaccharides enhanced T cells and macrophages to accelerate antitumor effects (Wang et al 2001). The crude water-soluble polysaccharides of H. erinaceus upregulated certain functional immunomodulating events mediated by activated macrophages, such as the production of nitric oxide (NO) and the expression of cytokines (IL-1β and TNF-β), which might be responsible for the anticancer properties of this mushroom (Lee et al 2009). H. erinaceus polysaccharides can improve immunity, provide antitumor, antiaging and other effects and have broad applications

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call